CD80 and arthritic joint disease: Furthermore, co-stimulatory B-cell surface molecules have their own role to play in T-cell responses; for example, a study demonstrated that in mouse bone marrow chimeras with CD80/86 knockout B-cells (but with other APCs retaining these CD markers), resistance to the induction of proteoglycan-induced arthritis was present.